Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Sakai

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|April 28, 2022
Immunological Correlates of Prevention of the Onset of Seasonal H3N2 InfluenzaMoe Okuda, Yuko Sakai-Tagawa, Michiko Koga, et al.
Vaccines|August 28, 2025
Impact of Vaccination and Prior Infection on SARS-CoV-2 Viral Load in Preschool Children During the Omicron PandemicMitsuyoshi Suzuki, Akifumi Tokita, Mariko Inaba, et al.
Internal Medicine (Tokyo, Japan)|January 3, 2024
Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological MalignanciesMasao Hagihara, Hiroyoshi Hayashi, Shiori Nakashima, et al.
Frontiers in Microbiology|July 11, 2018
Development of an Influenza Rapid Diagnostic Kit Specific for the H7 SubtypeKiyoko Iwatsuki-Horimoto, Jianzhong Shi, Xiurong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2012
Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphomaAtsushi Kawaguchi, Yasuo Iwadate, Yoshihiro Komohara, et al.
Scientific Reports|December 20, 2017
Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodiesAtsuhiro Yasuhara, Seiya Yamayoshi, Priyanka Soni, et al.
Viruses|June 14, 2020
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent MannerMizuki Yamamoto, Maki Kiso, Yuko Sakai-Tagawa, et al.
Nature Microbiology|June 15, 2022
Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamstersRyuta Uraki, Maki Kiso, Masaki Imai, et al.
Scientific Reports|November 5, 2017
Reactivity and sensitivity of commercially available influenza rapid diagnostic tests in JapanYuko Sakai-Tagawa, Seiya Yamayoshi, Chiharu Kawakami, et al.
Vaccine|September 23, 2008
Cross-clade protective immunity of H5N1 influenza vaccines in a mouse modelShin Murakami, Ayaka Iwasa, Kiyoko Iwatsuki-Horimoto, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|April 28, 2022
Immunological Correlates of Prevention of the Onset of Seasonal H3N2 InfluenzaMoe Okuda, Yuko Sakai-Tagawa, Michiko Koga, et al.
Vaccines|August 28, 2025
Impact of Vaccination and Prior Infection on SARS-CoV-2 Viral Load in Preschool Children During the Omicron PandemicMitsuyoshi Suzuki, Akifumi Tokita, Mariko Inaba, et al.
Internal Medicine (Tokyo, Japan)|January 3, 2024
Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological MalignanciesMasao Hagihara, Hiroyoshi Hayashi, Shiori Nakashima, et al.
Frontiers in Microbiology|July 11, 2018
Development of an Influenza Rapid Diagnostic Kit Specific for the H7 SubtypeKiyoko Iwatsuki-Horimoto, Jianzhong Shi, Xiurong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2012
Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphomaAtsushi Kawaguchi, Yasuo Iwadate, Yoshihiro Komohara, et al.
Scientific Reports|December 20, 2017
Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodiesAtsuhiro Yasuhara, Seiya Yamayoshi, Priyanka Soni, et al.
Viruses|June 14, 2020
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent MannerMizuki Yamamoto, Maki Kiso, Yuko Sakai-Tagawa, et al.
Nature Microbiology|June 15, 2022
Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamstersRyuta Uraki, Maki Kiso, Masaki Imai, et al.
Scientific Reports|November 5, 2017
Reactivity and sensitivity of commercially available influenza rapid diagnostic tests in JapanYuko Sakai-Tagawa, Seiya Yamayoshi, Chiharu Kawakami, et al.
Vaccine|September 23, 2008
Cross-clade protective immunity of H5N1 influenza vaccines in a mouse modelShin Murakami, Ayaka Iwasa, Kiyoko Iwatsuki-Horimoto, et al.
Pageof 10